News: Suppliers
30 October 2024
Riber’s year-to-date revenue grows 14% to €18.5m
For third-quarter 2024, molecular beam epitaxy (MBE) system maker Riber S.A. of Bezons, France has reported revenue of €4.7m, almost halving from €9.3m in Q2/2024 and down from €4m a year previously.
However, for the year to end-September 2024 revenue of €18.5m is up 14% year-on-year from €16.2m, driven by the company’s strengthened position in the MBE market for both research and industrial production.
Specifically, MBE Systems revenue rose by 28% from €9.6m to €12.3m (despite machine deliveries falling from five to four).
Services & Accessories revenue has fallen by 6% from €6.6m to €6.2m.
Of total year-to-date revenue, 68% came from Asia, 25% from Europe and 6% from North America.
Order book grows by 14%
The MBE Systems order book has grown by 16% from €27.6m to €31.9m (comprising 13 systems, including 8 production machines). However, this does not include the order for a production system announced on 21 October.
The Services & Accessories order book has risen by 6% from €6.1m to €6.4m.
The total order book has hence grown by 14% from €33.6m at end-September 2023 to €38.3m to end-September 2024.
Full-year revenue to grow to more than €40m
Based on the fourth-quarter delivery schedule, Riber expects full-year revenue to exceed €40m, along with further improvements in earnings.
Also, against a favorable backdrop of growth in the compound semiconductor market, new orders should continue to be booked before the end of 2024.
Riber secures order for MBE 49 GaN system
VEXLUM orders Riber MBE 412 cluster system
Riber reports positive earnings in first-half 2024, as revenue grows by 13%
Riber receives repeat order for MBE 412 cluster platform
Riber’s Q1 revenue up 20% year-on-year
Riber’s annual revenue grows 41% to €39.3m, driven by systems revenue almost doubling
